Glaukos (GKOS): Market Value

This price chart for Glaukos Corporation (GKOS) reflects a market value of 14.54. The business relies on exclusive glaucoma treatment patents and stringent FDA oversight. Growth is driven by the implementation of innovative devices and the expansion of insurance coverage. Capital stability is maintained through diversification between pharmaceutical production and specialized equipment for ophthalmology centers.

GKOS Glaukos: Market Capitalization in the range 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Glaukos Corporation (GKOS)

- market price and analyst price targets:

Price Chart Glaukos Corp|GKOS - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value Glaukos Medical|GKOS - Total Enterprise Value

- book value of equity indicators:

Net Assets per Single Share Glaukos|GKOS - Book Valuation of Business|Market Value to Book Value Ratio glaukos.com|GKOS - Total Asset Value of Company

- debt and liquidity data:

- business earnings and investment ratios data:

GKOS - Net Profit|Future Profit Glaukos Corporation|GKOS - Company Value to Net Income|Forward P/E Multiple Glaukos Corp|GKOS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Glaukos Medical|GKOS - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Glaukos|GKOS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months glaukos.com|GKOS - Expected net earnings per share growth this year|Earnings growth forecast for next year Glaukos Corporation

- sales volume and revenue indicators:

GKOS - Company Total Sales Volume|Company Projected Revenue Glaukos Corp.|GKOS - Price-to-Revenue Ratio|Forward P/S Multiple Glaukos

Fundamental company analysis:GKOS (Glaukos Corp.)

A comparative analysis of market value allows an investor to determine an asset's weight within a sector, where the total number of shares multiplied by the current price reflects the market's overall valuation of the business's fundamental potential. Stable demand for micro-implants driven by an aging population minimizes volatility, making the current capitalization level of Glaukos Corporation (GKOS) a reliable indicator of long-term sustainability.

Key competitors